TGFB1 and neoplasm: ,7 However, NK cells are usually short-lived, and the clinical efficacy of NK cells is often compromised by their limited persistence as well as tumor-intrinsic immunosuppressive microenvironments where transforming growth factor β (TGF-β) plays a central role in inhibiting NK cell functions.